相关实验视频

Updated: May 11, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

高风险心肌梗塞后早期康复阶段的NT-proBNP与心血管不良结果有关:PARADISE-MI试验

Karola S Jering¹, Brian L Claggett¹, Eugene Braunwald²

¹Cardiovascular Division, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.

Journal of cardiac failure

|April 18, 2025

概括

在心肌梗塞 (MI) 发生两周后,N-终端B型亲尿素 (NT-proBNP) 水平升高表明心力衰竭,复发事件和死亡风险更高. 这种早期标志物有助于识别需要加强预防护理的高风险患者.

科学领域:

心脏病学心脏病学
生物标志物生物标志物
心脏衰竭研究研究

背景情况:

N-终端亲B型尿素 (NT-proBNP) 与心力衰竭 (HF) 住院和心肌梗塞 (MI) 后死亡率有关.
在心脏病发作后的早期康复阶段NT-proBNP的预后值不太清楚.

研究的目的:

评估NT-proBNP水平在高风险心脏病发作后的早期康复阶段的预后意义.
为了确定第二周的NT-proBNP度是否预测了随后的临床结果.

主要方法:

分析了PARADISE-MI试验中的1062名患有MI,LVEF≤40%,或肺堵塞的患者.
使用考克斯模型进行里程碑式分析,以评估第二周NT-proBNP与临床结果之间的关联,并对共变量进行调整.

主要成果:

在第二周,较高的NT-proBNP度独立地与心血管死亡或HF (aHR1.65),HF住院 (aHR1.87),复发性心脏病 (aHR1.46) 和全因死亡 (aHR1.85) 的风险增加有关.
在最高NT-proBNP四分位数中的患者年龄较大,LVEF和eGFR较低,Killip类较高,心房动较多.

结论:

在心脏病发作后大约2周的NT-proBNP升高确定了患有HF,冠状动脉复发和死亡风险较高的患者.
早期康复阶段的NT-proBNP水平可以帮助风险分层和识别需要先进预防治疗的患者.

关键词:

早期康复阶段的早期康复阶段心脏衰竭是因为心脏衰竭.心肌梗塞的心脏病发作这是一种天然尿素.风险分层的风险分层.

更多相关视频

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

相关概念视频

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...